Patients with the Li Fraumeni syndrome, which is an autosomal dominant cancer predisposition disorder caused by some p53 mutations, have increased oxidative phosphorylation of skeletal muscle50. The gene discussed is TP53; the disease is Li-Fraumeni syndrome.